|
| Roundtable Discussion with Dr Kim, Jang-Seong (KRIBB), Profs Choi, Insung (KAIST) and MOK, K. Hun (Trinity College Dublin) |
| DR. KIM, Jang-seong |
| Korea Research Institute of Bioscience and Biotechnology (KRIBB) |
| Jang-Seong Kim, Ph.D., is the president of the Korea Research Institute of Bioscience and Biotechnology (KRIBB). Since having taken office in July, 2018 – spanning over 5 years – he has been overseeing the work of the Korea’s one and only government life science research institution, from basic research to public research infrastructure contributing to the public health and national bioeconomy.
Dr. Kim is a cancer biologist noted for his lead of new drug development, especially in anti-cancer drug, from the basics to clinical trials pioneering Korea’s translational research.
Dr. Kim received a Ph.D. in cancer biology from Korea Advanced Institute of Science and Technology (KAIST). Prior to coming to KRIBB in 2010, he spent over 20 years at the MD Anderson Cancer Center and major pharmaceutical companies. He is an active member of American Association for Cancer Research and was awarded the Order of Science and Technology Merit, Republic of Korea in April, 2018. |
|
|